Xeris Pharmaceuticals shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Xeris Pharmaceuticals (XERS) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Xeris Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Xeris Pharmaceuticals held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Xeris Pharmaceuticals by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $7.4M | 905k | 8.14 |
| 2025-03-31 | $12M | 2.1M | 5.49 |
| 2024-12-31 | $3.5M | 1.0M | 3.39 |
| 2024-09-30 | $1.1M | 392k | 2.85 |
| 2024-06-30 | $730k | 324k | 2.25 |
| 2024-03-31 | $827k | 374k | 2.21 |
| 2023-12-31 | $758k | 322k | 2.35 |
| 2023-09-30 | $218k | 117k | 1.86 |
| 2023-06-30 | $792k | 302k | 2.62 |
| 2023-03-31 | $1.1M | 665k | 1.60 |
| 2022-12-31 | $126k | 94k | 1.33 |
| 2022-06-30 | $123k | 80k | 1.54 |
| 2022-03-31 | $48k | 19k | 2.58 |
| 2021-12-31 | $39k | 13k | 2.93 |